EyeTube Video Interview with ELZA founder Farhad Hafezi: a new technology to perform cross-linking at the slit lamp might change the way we will treat corneal infection and keratoconus in the future.
ELZA’s presence at the EUCornea and ESCRS meeting: Six presentations in Symposia and Courses.
We proudly announce that the second edition of our medical textbook “Corneal Cross-Linking” will soon appear with Slack Inc.
The Geneva University Spin-off company EMAGine will present the C-Eye device. This mobile cross-linking technology will allow for slit lamp cross-linking (CXL and PACK-CXL) treatments.
Interview with the ELZA co-founder Prof. Farhad Hafezi, explaining the latest international multicenter trial on epithelium-on cross-linking led by ELZA, and why epi-on still is not (yet) the way to go in 2016
The present study describes the clinical outcomes of the Argus II retinal prosthesis in patients with Retinitis Pigmentosa (RP) or outer retinal degeneration
The National Keratoconus Foundation in the US highlights the work of the ELZA member Nikki Hafezi and the Swiss Light for Sight foundation, providing keratoconus treatment for children and adolescents, with special emphasis on Down Syndrome
Epi-on Cross-Linking has so far been disappointing in terms of clinical outcomes. It is clearly inferior to the classic epi-off treatment.
The 24th National Ophthalmology Meeting of the Lebanese Society of Ophthalmology is organized by the American University of Beirut (AUB).
Farhad Hafezi receives the 2016 El-Maghraby International Award for his contributions to ophthalmology.
